Lifecore Biomedical, Inc.
LFCR
$4.93
-$0.05-1.00%
NASDAQ
| 03/31/2026 | 09/30/2025 | 05/25/2025 | 05/25/2025 | 02/23/2025 | |
|---|---|---|---|---|---|
| Net Income | -- | -32.48M | -38.72M | -38.72M | -44.65M |
| Total Depreciation and Amortization | -- | 8.02M | 8.03M | 8.03M | 8.13M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -- | 38.19M | 35.18M | 35.18M | 38.91M |
| Change in Net Operating Assets | -- | -11.52M | -4.70M | -4.70M | 775.00K |
| Cash from Operations | -- | 2.20M | -206.00K | -206.00K | 3.16M |
| Capital Expenditure | -- | -11.76M | -13.42M | -13.42M | -14.03M |
| Sale of Property, Plant, and Equipment | -- | 7.00M | 7.00M | 7.00M | 7.00M |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -4.76M | -6.42M | -6.42M | -7.03M |
| Total Debt Issued | -- | 138.75M | 128.57M | 128.57M | 146.48M |
| Total Debt Repaid | -- | -157.86M | -145.76M | -145.76M | -164.11M |
| Issuance of Common Stock | -- | 23.86M | 23.86M | 23.86M | 23.86M |
| Repurchase of Common Stock | -- | -1.85M | -1.28M | -1.28M | -1.88M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 1.04M | 1.04M | 1.04M | 1.87M |
| Cash from Financing | -- | 3.94M | 6.42M | 6.42M | 6.21M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -- | 1.38M | -197.00K | -197.00K | 2.34M |